Abstract
Protein tyrosine phosphatase (PTP) 1B is a potential target for the treatment of diabetes and obesity. Phosphotyrosine (pTyr) is the substrate for PTP1B dephosphorylation. Malonic acid moiety was used herein as a mimic of the phosphate group in pTyr, and novel malonic acid derivatives 1-7 were designed, synthesized and evaluated as PTP1B inhibitors. Results from enzymatic assays indicated that compounds 3 and 4 exhibited potent inhibition against human recombinant PTP1B with IC50 values of 7.66 and 1.88 micromol x L(-1), respectively.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Design*
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
Malonates / chemical synthesis*
-
Malonates / chemistry
-
Malonates / pharmacology
-
Molecular Structure
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
-
Structure-Activity Relationship
Substances
-
Enzyme Inhibitors
-
Malonates
-
malonic acid
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1